Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. IOVA
IOVA logo

IOVA

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IOVA News

Avaí Bio Initiates Key Cell Bank Project for Therapy Development

6d agoPRnewswire

Avaí Bio Initiates Key Cell Bank Project for Therapy Development

6d agoNewsfilter

How Two Small Biotech Companies Could Pave the Way for Innovative Cancer Therapies

Mar 12 2026Marketbeat

Iovance Biotherapeutics Stock Rises Amid High Short Interest

Mar 06 2026Benzinga

Iovance Biotherapeutics: High-Risk, High-Reward Potential

Mar 05 2026Fool

Iovance Biotherapeutics Faces Challenges and Opportunities

Mar 05 2026NASDAQ.COM

ImmunityBio and Iovance Stock Dynamics Analysis

Mar 05 2026stocktwits

Wall Street Analysts Adjust Ratings on Key Stocks

Mar 03 2026Benzinga

Significant Milestones in Biotech Sector This Week

Feb 27 2026NASDAQ.COM

Wall Street Analysts Adjust Ratings

Feb 25 2026Benzinga

Iovance Biotherapeutics Reports Record Q4 Margins and Strong Upside Potential

Feb 25 2026stocktwits

Iovance Biotherapeutics Shares Surge on Positive Clinical Trial Data

Feb 24 2026Benzinga

Iovance Biotherapeutics Q4 2025 Earnings Highlights

Feb 24 2026seekingalpha

Semiconductor Stocks Show Strong Gains

Feb 24 2026NASDAQ.COM

Iovance Biotherapeutics Q4 Results Beat Expectations with Promising Trial Data

Feb 24 2026seekingalpha

Iovance Biotherapeutics Shares Surge 22% on Positive Clinical Trial Results

Feb 24 2026NASDAQ.COM